Griffith & Werner Inc. acquired a new position in MetLife, Inc. (NYSE:MET – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 2,705 shares of the financial services provider’s stock, valued at approximately $221,000.
Several other institutional investors have also added to or reduced their stakes in the company. United Asset Strategies Inc. raised its holdings in shares of MetLife by 1.1% in the fourth quarter. United Asset Strategies Inc. now owns 10,933 shares of the financial services provider’s stock worth $895,000 after buying an additional 120 shares during the period. Barrett & Company Inc. grew its position in MetLife by 1.0% in the 4th quarter. Barrett & Company Inc. now owns 11,942 shares of the financial services provider’s stock valued at $978,000 after acquiring an additional 121 shares during the last quarter. Eagle Strategies LLC increased its stake in MetLife by 4.8% in the fourth quarter. Eagle Strategies LLC now owns 2,707 shares of the financial services provider’s stock worth $222,000 after purchasing an additional 123 shares during the period. J.W. Cole Advisors Inc. increased its stake in MetLife by 2.1% in the fourth quarter. J.W. Cole Advisors Inc. now owns 6,044 shares of the financial services provider’s stock worth $495,000 after purchasing an additional 126 shares during the period. Finally, Davis R M Inc. lifted its position in shares of MetLife by 4.2% during the fourth quarter. Davis R M Inc. now owns 3,148 shares of the financial services provider’s stock worth $258,000 after purchasing an additional 127 shares during the last quarter. Institutional investors own 94.99% of the company’s stock.
Analyst Ratings Changes
MET has been the topic of several recent analyst reports. Morgan Stanley raised their price target on shares of MetLife from $94.00 to $99.00 and gave the stock an “overweight” rating in a research note on Monday, May 19th. Keefe, Bruyette & Woods dropped their target price on shares of MetLife from $98.00 to $95.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 9th. JPMorgan Chase & Co. reduced their target price on shares of MetLife from $88.00 to $86.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 2nd. Wall Street Zen lowered MetLife from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Wells Fargo & Company increased their price objective on MetLife from $91.00 to $94.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 6th. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $94.17.
MetLife Price Performance
NYSE MET opened at $77.20 on Friday. The company has a market cap of $51.82 billion, a PE ratio of 12.93, a P/E/G ratio of 0.65 and a beta of 0.85. The firm’s 50 day moving average price is $76.89 and its 200-day moving average price is $81.12. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a 52-week low of $65.21 and a 52-week high of $89.05.
MetLife (NYSE:MET – Get Free Report) last posted its earnings results on Wednesday, April 30th. The financial services provider reported $1.96 earnings per share for the quarter, missing analysts’ consensus estimates of $2.00 by ($0.04). MetLife had a return on equity of 20.42% and a net margin of 6.19%. The company had revenue of $18.57 billion for the quarter, compared to analysts’ expectations of $18.06 billion. During the same quarter in the prior year, the company earned $1.83 EPS. The firm’s quarterly revenue was up 15.6% on a year-over-year basis. Sell-side analysts forecast that MetLife, Inc. will post 9.65 EPS for the current fiscal year.
MetLife Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 10th. Investors of record on Tuesday, May 6th will be given a dividend of $0.5675 per share. The ex-dividend date is Tuesday, May 6th. This represents a $2.27 dividend on an annualized basis and a yield of 2.94%. This is an increase from MetLife’s previous quarterly dividend of $0.55. MetLife’s dividend payout ratio (DPR) is presently 36.91%.
MetLife declared that its Board of Directors has approved a share buyback program on Wednesday, April 30th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to purchase up to 5.9% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s board believes its stock is undervalued.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Why Invest in 5G? How to Invest in 5G Stocks
- MarketBeat Week in Review – 05/19 – 05/23
- Best Stocks Under $10.00
- Pfizer’s 7.5% Dividend: Income Haven or House of Cards?
- The How And Why of Investing in Oil Stocks
- 3 Trades Members of Congress Are Making Right Now
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.